BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/3/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
(AMEX: BNXTF) Delayed: 0.27 --0 (-0%)
Previous Close $0.27    52 Week High $ 
Open $0.27    52 Week Low $ 
Day High $0.27    P/E N/A 
Day Low $0.27    EPS $ 
Volume 90